Fibrinogen and LDL apheresis in treatment of sudden hearing loss: A randomised multicentre trial

Lancet

Volumn 360, Issue 9348, 2002, Pages 1811-1817

  Suckfull M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; HETASTARCH; LOW DENSITY LIPOPROTEIN; PENTOXIFYLLINE; PREDNISOLONE;

ADULT; APHERESIS; ARTICLE; AUDIOMETRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPEECH AUDIOMETRY; SPEECH PERCEPTION; SUDDEN DEAFNESS; TIME; TINNITUS; TREATMENT OUTCOME;

EID: 0037038824     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11768-5     Document Type: Article

References (30)

1. Byl F.M. Jr. Sudden hearing loss: eight years experience and suggested prognostic table. Laryngoscope. 94:1984;647-661.
2. Miller J., Dengerink H. Control of inner ear blood flow. Am J Otolaryngol. 9:1988;302-316.
3. Probst R., Tschopp K., Lüdin E., Kellerhals B., Podvinec M., Pfaltz R. A randomized, double-blind, placebo-controlled study of dextran/pentoxifylline medication in acute acoustic trauma and sudden hearing loss. Acta Otolaryngol. 112:1992;435-443.
4. Suckfüll M., Thiery J., Schorn K., Kastenbauer E., Seidel D. Clinical utility of LDL-apheresis in the treatment of sudden hearing loss: a prospective, randomized study. Acta Otolaryngol. 119:1999;763-766.
5. Schuff-Werner P., Schütz E., Seyde W.C., et al. Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP). Euro J Clin Invest. 19:1989;30-37.
6. Megighian D., Savastano M., Salvador L., Frigo A., Bolzan M. Audiometric and epidemiological analysis of elderly in the Veneto region. Gerontology. 46:2000;199-204.
7. Wilson W., Byl F., Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss: a double blind clinical study. Arch Otolaryngol. 106:1980;772-776.
8. Moskowitz D., Lee K., Smith H.W. Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope. 94:1984;664-666.
9. Alexiou C., Arnold W., Fauser C., et al. Sudden sensorineural hearing loss: does application of glucocorticoids make sense? Arch Otolaryngol Head Neck Surg. 127:2001;253-258.
10. Kojima Y., Ito S., Furuya N. Hearing improvement after therapy for hyperlipidemia in patients with chronic-phase sudden deafness. Ann Otol Rhinol Laryngol. 110:2001;105-108.
11. Pyykkö I., Koskimies K., Starck J., Pekkarinen J., Inaba R. Evaluation of factors affecting sensory neural hearing loss. Acta Otolaryngol. 449:1988;155-158.
12. Gates G., Cobb J., D'Agostino R., Wolf P. The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch Otolaryngol Head Neck Surg. 119:1993;156-161.
13. Gatehouse S., Gallacher J., Lowe G., Yarnell J., Hutton R., Ising I. Blood viscosity and hearing levels in the Caerphilly Collaborative Heart Disease Study. Arch Otolaryngol Head Neck Surg. 115:1989;1227-1230.
14. Axelsson A., Lindgren F. Is there a relationship between hypercholesterolaemia and noise-induced hearing loss? Acta Otolaryngol. 100:1985;379-386.
15. Ciuffetti G., Scardazza A., Serafini G., Lombardini R., Mannarino E., Simoncelli C. Whole-blood filterability in sudden deafness. Laryngoscope. 101:1991;65-67.
16. Ohinata Y., Makimoto K., Kawakami M., Haginomori S., Araki M., Takahashi H. Blood viscosity and plasma viscosity in patients with sudden deafness. Acta Otolaryngol. 114:1994;601-607.
17. Suzuki K., Kaneko M., Murai K. Influence of serum lipids on auditory function. Laryngoscope. 110:2000;1736-1738.
18. Ernst E., Resch K. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med. 118:1993;956-963.
19. Kawakami M., Makimoto K., Yamamoto H., Takahashi H. The effect of Batrxobin on cochlear blood flow. Acta Otolaryngol. 112:1992;991-997.
20. Shiraishi T., Kubo T., Okumura S., et al. Hearing recovery in sudden deafness patients using a modified defibrinogenation therapy. Acta Otolaryngol. 501:(suppl):1993;46-50.
21. Fessenden J., Schacht J. The nitric oxide/cyclic GMP pathway: A potential major regulator of cochlear physiology. Hear Res. 118:1998;168-176.
22. Zeiher A., Drexler H., Saurbier B., Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest. 92:1993;652-662.
23. John S., Schlaich M., Langenfeld M., et al. Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients. Circulation. 98:1997;211-216.
24. Seidel D. HELP apheresis therapy in the treatment of severe hypercholesterolemia: 10 years of clinical experience. Artif Organs. 20:1996;303-310.
25. Pfefferkorn T.K., Knuppel H.P., Jaeger B.R., Thiery J., Hamann G.F. Increased cerebral CO(2) reactivity after heparin-mediated extracorporal LDL precipitation (HELP) in patients with coronary heart disease and hyperlipidemia. Stroke. 30:1999;1802-1806.
26. Mellwig K., Baller D., Gleichmann U., et al. Improvement of coronary vasodilatation capacity through single LDL apheresis. Atherosclerosis. 139:1998;173-178.
27. Nguyen T., Brownell W. Contribution of membrane cholesterol to outer hair cell lateral wall stiffness. Hear Res. 119:1998;14-20.
28. Saito T., Aran J.M. Comparative ototoxicity of cisplatin during acute and chronic treatment. ORL J Otorhinolaryngol Relat Spec. 56:1994;315-320.
29. Mattox D., Simmons F. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 86:1977;463-480.
30. Fetterman B., Saunders E., Luxford W. Prognosis and treatement of sudden sensorineural hearing loss. Am J Otolaryngol. 17:1996;529-536.